This dual mechanism not only supports weight loss but also helps manage blood sugar levels, reducing the likelihood of developing high blood pressure and other metabolic conditions
PlexusDx also offers oral semaglutide (at $289/mo month-to-month, or from $249/mo on the 6-month plan) for those preferring tablet form, as well as tirzepatidea dual GIP/GLP-1 agonist with potentially stronger anti-inflammatory properties
doi: 10.3390/ejihpe13080110
Wegovy is contraindicated in pregnancy and breastfeeding
Clinical use and practical aspects Patients who need further intensification of therapy but have had it delayed because of concerns about potential weight gain and hypoglycemic episodes would probably benefit from fixed-ratio combination of basal insulin and GLP-1Ras [19, 22, 23, 25,26,27, 30, 31]